94 related articles for article (PubMed ID: 11249709)
1. Myoglobin-loaded gadolinium nanotexaphyrins for oxygen synergy and imaging-guided radiosensitization therapy.
Ma X; Liang X; Yao M; Gao Y; Luo Q; Li X; Yu Y; Sun Y; Cheng MHY; Chen J; Zheng G; Shi J; Wang F
Nat Commun; 2023 Oct; 14(1):6187. PubMed ID: 37794000
[TBL] [Abstract][Full Text] [Related]
2. Ultrasmall Gd@Cdots as a radiosensitizing agent for non-small cell lung cancer.
Lee C; Liu X; Zhang W; Duncan MA; Jiang F; Kim C; Yan X; Teng Y; Wang H; Jiang W; Li Z; Xie J
Nanoscale; 2021 May; 13(20):9252-9263. PubMed ID: 33982686
[TBL] [Abstract][Full Text] [Related]
3. Impact of Broadening Trial Eligibility Criteria on the Inclusion of Patients With Brain Metastases in Cancer Clinical Trials: Time Series Analyses for 2012-2022.
Xiao H; Vaidya R; Hershman DL; Unger JM
J Clin Oncol; 2024 Jun; 42(16):1953-1960. PubMed ID: 38537158
[TBL] [Abstract][Full Text] [Related]
4. Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors.
Ellingson BM; Gerstner ER; Lassman AB; Chung C; Colman H; Cole PE; Leung D; Allen JE; Ahluwalia MS; Boxerman J; Brown M; Goldin J; Nduom E; Hassan I; Gilbert MR; Mellinghoff IK; Weller M; Chang S; Arons D; Meehan C; Selig W; Tanner K; Alfred Yung WK; van den Bent M; Wen PY; Cloughesy TF
Neuro Oncol; 2022 Aug; 24(8):1219-1229. PubMed ID: 35380705
[TBL] [Abstract][Full Text] [Related]
5. Brain metastases: treatment options to improve outcomes.
Davey P
CNS Drugs; 2002; 16(5):325-38. PubMed ID: 11994022
[TBL] [Abstract][Full Text] [Related]
6. Motexafin gadolinium (Gd-Tex) selectively induces apoptosis in HIV-1 infected CD4+ T helper cells.
Perez OD; Nolan GP; Magda D; Miller RA; Herzenberg LA; Herzenberg LA
Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2270-4. PubMed ID: 11854523
[TBL] [Abstract][Full Text] [Related]
7. Motexafin gadolinium: gadolinium (III) texaphyrin, gadolinium texaphyrin, Gd-Tex, GdT2B2, PCI 0120.
Drugs R D; 2004; 5(1):52-7. PubMed ID: 14725495
[TBL] [Abstract][Full Text] [Related]
8. A phase I single-dose trial of gadolinium texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging.
Rosenthal DI; Nurenberg P; Becerra CR; Frenkel EP; Carbone DP; Lum BL; Miller R; Engel J; Young S; Miles D; Renschler MF
Clin Cancer Res; 1999 Apr; 5(4):739-45. PubMed ID: 10213207
[TBL] [Abstract][Full Text] [Related]
9. Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
Drugs R D; 2005; 6(3):178-85. PubMed ID: 15869322
[TBL] [Abstract][Full Text] [Related]
10. Tezacitabine Hoechst Marion Roussel.
Seley KL
Curr Opin Investig Drugs; 2000 Sep; 1(1):135-40. PubMed ID: 11249589
[TBL] [Abstract][Full Text] [Related]
11. Exisulind Cell Pathways.
Griffiths GJ
Curr Opin Investig Drugs; 2000 Nov; 1(3):386-91. PubMed ID: 11249724
[TBL] [Abstract][Full Text] [Related]
12. Gd-Tex Pharmacyclics Inc.
Radford IR
Curr Opin Investig Drugs; 2000 Dec; 1(4):524-8. PubMed ID: 11249709
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
